Association between biochemical hyperandrogenism parameters and Ferriman‐Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta‐regression analysis

Abstract

Summary: Background and Objective: A limited number of studies have evaluated the relationship between clinical and biochemical hyperandrogenism (HA). This study aimed to evaluate the association between biochemical hyperandrogenism parameters (BHP s) and Ferriman‐Gallwey (FG) score in patients with polycystic ovary syndrome (PCOS). Methods: We searched PubMed, Scopus, Google Scholar, ScienceDirect and Web of Sciences databases (2000‐2015) to identify studies investigating clinical and biochemical parameters of HA in PCOS patients. In this meta‐analysis, both fixed and random effect models were applied to estimate pooled effect size. To assess the relationships between BHP s and FG score, meta‐regression analysis was used. Results: Fifty‐five study groups with a total of 6593 PCOS patients were analysed. Meta‐regression analysis of pooled data from all eligible studies showed significant positive relationships of FG score with androstenedione (A4) (P=.034) and dehydroepiandrosterone sulphate (DHEAS) (P=.012), whereas it showed no association with total testosterone (tT), free testosterone (fT), sex hormone bonding globulin (SHBG) and free androgen index (FAI). The results did not change after adjusting for quality assessment or method of assay. Nor did the associations between A4 and FG score remain after adjusting for age and BMI, diagnostic criteria for PCOS and study design or the association between DHEAS and FG score remain after adjusting for ethnicity. Conclusion: This meta‐analysis confirmed the associations of some BHP s, including A4 and DHEAS with FG score, indicating that measurement of these parameters can be useful for managing PCOS patients with hirsutism.